Plasma chitotriosidase activity in multiple sclerosis

Clinical Immunology

Volumn 131, Issue 2, 2009, Pages 216-222

  Comabella, M ^a   Dominguez C ^b,c   Rio, J ^a   Martin Gallan P ^b,c   Vilches, A ^b,c   Vilarrasa, N ^a   Espejo, C ^a   Montalban, X ^a  

^a CEM Cat   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Chitotriosidase; Innate immunity; Interferon beta; Multiple sclerosis

Indexed keywords

BETA INTERFERON; CHITOTRIOSIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLUOROMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE;

ADULT; FEMALE; HEXOSAMINIDASES; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; REFERENCE STANDARDS; UP-REGULATION;

EID: 63749131581     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.12.004     Document Type: Article

References (23)

1. Den Tandt W.R., Inaba T., Verhamme I., Overdyk B., Brouwer J., and Prieur D. Non-identity of human plasma lysozyme and 4-methylumbelliferyl-tetra-N-acetyl-beta-D-chitotetraoside hydrolase. Int. J. Biochem. 20 (1988) 713-719
2. Bouzas L., Carlos Guinarte J., and Carlos Tutor J. Chitotriosidase activity in plasma and mononuclear and polymorphonuclear leukocyte populations. J. Clin. Lab. Anal. 17 (2003) 271-275
3. Van Eijk M., Van Roomen C.P., Renkema G.H., Bussink A.P., Andrews L., Blommaart E.F., Sugar A., Verhoeven A.J., Boot R.G., and Aerts J.M. Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int. Immunol. 17 (2005) 1505-1512
4. Guo Y., He W., Boer A.M., Wevers R.A., De Bruijn A.M., Groener J.E., Hollak C.E., Aerts J.M., Galjaard H., and Van Diggelen O.P. Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J. Inherit. Metab. Dis. 18 (1995) 717-722
5. Hollak C.E., Van Weely S., Van Oers M.H., and Aerts J.M. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J. Clin. Invest. 93 (1994) 1288-1292
6. Barone R., Di Gregorio F., Romeo M.A., Schiliro G., and Pavone L. Plasma chitotriosidase activity in patients with beta-thalassemia. Blood Cells Mol. Dis. 25 (1999) 1-8
7. Boot R.G., Van Achterberg T.A., Van Aken B.E., Renkema G.H., Jacobs M.J., Aerts J.M., and De Vries C.J. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 687-694
8. Barone R., Simpore J., Malaguarnera L., Pignatelli S., and Musumeci S. Plasma chitotriosidase activity in acute Plasmodium falciparum malaria. Clin. Chim. Acta. 331 (2003) 79-85
9. Grosso S., Margollicci M.A., Bargagli E., Buccoliero Q.R., Perrone A., Galimberti D., Morgese G., Balestri P., and Rottoli P. Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis. Scand. J. Clin. Lab. Invest. 64 (2004) 57-62
10. Boot R.G., Renkema G.H., Verhoek M., Strijland A., Bliek J., De Meulemeester T.M., Mannens M.M., and Aerts J.M. The human chitotriosidase gene. Nature of inherited enzyme deficiency. J. Biol. Chem. 273 (1998) 25680-25685
11. Boot R.G., Renkema G.H., Strijland A., Van Zonneveld A.J., and Aerts J.M. Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J. Biol. Chem. 270 (1995) 26252-26256
12. Malaguarnera L., Simpore J., Prodi D.A., Angius A., Sassu A., Persico I., Barone R., and Musumeci S. A 24-bp duplication in exon 10 of human chitotriosidase gene from the sub-Saharan to the Mediterranean area: role of parasitic diseases and environmental conditions. Genes Immun. 4 (2003) 570-574
13. Sotgiu S., Barone R., Arru G., Fois M.L., Pugliatti M., Sanna A., Rosati G., and Musumeci S. Intrathecal chitotriosidase and the outcome of multiple sclerosis. Mult. Scler. 12 (2006) 551-557
14. Lublin F.D., and Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46 (1996) 907-911
15. Rio J., Nos C., Tintore M., Tellez N., Galan I., Pelayo R., Comabella M., and Montalban X. Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients. Ann. Neurol. 59 (2006) 344-352
16. Bierbaum S., Superti-Furga A., and Heinzmann A. Genetic polymorphisms of chitotriosidase in Caucasian children with bronchial asthma. Int. J. Immunogenet. 33 (2006) 201-204
17. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 23 (2005) 683-747
18. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group. Neurology 43 (1993) 655-661
19. Jacobs L.D., Cookfair D.L., Rudick R.A., Herndon R.M., Richert J.R., Salazar A.M., Fischer J.S., Goodkin D.E., Granger C.V., Simon J.H., Alam J.J., Bartoszak D.M., Bourdette D.N., Braiman J., Brownscheidle C.M., Coats M.E., Cohan S.L., Dougherty D.S., Kinkel R.P., Mass M.K., Munschauer III F.E., Priore R.L., Pullicino P.M., Scherokman B.J., Whitham R.H., et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann. Neurol. 39 (1996) 285-294
20. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Lancet 352 (1998) 1498-1504
21. Le Page C., Genin P., Baines M.G., and Hiscott J. Interferon activation and innate immunity. Rev. Immunogenet. 2 (2000) 374-386
22. Filion L.G., Matusevicius D., Graziani-Bowering G.M., Kumar A., and Freedman M.S. Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis. Clin. Immunol. 106 (2003) 127-138
23. Filion L.G., Graziani-Bowering G., Matusevicius D., and Freedman M.S. Monocyte-derived cytokines in multiple sclerosis. Clin. Exp. Immunol. 131 (2003) 324-334